In both vertebrates and invertebrates, glial cells wrap axonal processes to ensure electrical conductance. Here we report that Crooked neck (Crn), the Drosophila homolog of the yeast Clf1p splicing factor, is directing peripheral glial cell maturation. We show that crooked neck is expressed and required in glial cells to control migration and axonal wrapping. Within the cytoplasm, Crn interacts with the RNA-binding protein HOW and then translocates to the nucleus where the Crn/HOW complex controls glial differentiation by facilitating splicing of specific target genes. By using a GFP-exon trap approach, we identified some of the in vivo target genes that encode proteins localized in autocellular septate junctions. In conclusion, here we show that glial cell differentiation is controlled by a cytoplasmic assembly of splicing components, which upon translocation to the nucleus promote the splicing of genes involved in the assembly of cellular junctions.
Introduction
The development of a complex nervous system requires intensive interactions between its two major cell types: neurons and glial cells. During the course of evolution, the relative number of glial cells increases concomitantly with the computing abilities of the nervous system. The main functional roles of neurons and glial cells, however, have not changed very much (Freeman and Doherty, 2006; Granderath and Klä mbt, 1999; Lemke, 2001) . Neurons are required to perceive, integrate, and transmit information, whereas glial cells exert numerous tasks to keep neurons functional.
The list of functional attributes assigned to the glia is long and still growing. Early on in development, glial cells regulate neuronal cell number and have the ability to direct or restrict axonal growth (Hidalgo and ffrench-Constant, 2003) . Besides these developmental roles, glial cells insulate individual axons or groups of axons, so-called fascicles, in the vertebrate or the invertebrate nervous system, respectively (Sherman and Brophy, 2005) . Furthermore, glial cells insulate the entire nervous system and participate in the formation of an impermeable barrier that allows keeping a relatively constant ionic milieu required for optimal neuronal functionality Carlson et al., 2000; Schwabe et al., 2005) .
In addition, the isolation of axons allows faster conductance and helps to reduce electrical crosstalk between different axons. Invertebrate and vertebrate glial cells have evolved seemingly different cell-biological strategies. Vertebrate glia is capable of forming the so-called myelin sheets around the axon, whereas in the invertebrate nervous system no myelin is formed (Edenfeld et al., 2005; Sherman and Brophy, 2005) .
Superficially, the vertebrate myelin is profoundly different from the simply wrapped fascicles found in most invertebrates. However, in several invertebrate species axons can be wrapped multiple times in a way that structurally very much resembles myelin structures (Davis et al., 1999; Lenz et al., 2000; Weatherby et al., 2000) . A major difference between glial cells in the two animal phyla is the missing compaction of glial cell membranes in invertebrates.
In Drosophila, early gliogenesis is well characterized (Jones, 2005; Van De Bor and Giangrande, 2002) . Within the embryonic nerve cord, only 70 glial cells are found in every neuromeric unit (Ito et al., 1995; . Once specified, many glial cells often migrate toward their final destinations, where they eventually differentiate to wrap the axonal membranes. The peripheral glial cells in the embryonic nervous system of Drosophila originate from stem cells located at the CNS/PNS boundary. During later nervous system development, motoneurons project their axons toward the muscle fields in the lateral body wall. The peripheral glial cells will follow the motoneurons toward very stereotyped positions along the nerve (Pielage et al., 2004; Sepp and Auld, 2003b; Sepp et al., 2000 Sepp et al., , 2001 .
In the wild-type, glial migration occurs in two separable phases. First, a thin glial cell process navigates along the axon, which is then followed by the cell body that subsequently initiates wrapping of the nerve bundle (Sepp et al., 2000; Edenfeld et al., 2006) . Glial migration is known to require small GTPases, but only few mutants have been described that affect glial differentiation (Banerjee et al., 2006; Leiserson et al., 2000) .
In order to understand how peripheral glial cells switch from migration to subsequent differentiation, we have initiated a genetic screen for mutants affecting glial development. Here we present the analysis of one mutant identified in this screen, crooked neck (crn). In crn mutants, the migration and subsequent differentiation is impaired, and axonal processes are not properly wrapped. The Crooked neck protein is well conserved during evolution, and its human and yeast homologs have been described as factors regulating mRNA splicing by controlling the assembly of the spliceosome complex (Burnette et al., 1999; Chung et al., 1999 Chung et al., , 2002 Ohi and Gould, 2002; Park et al., 2004; Raisin-Tani and Leopold, 2002; Wang et al., 2003) . Here we show that the Crooked neck protein is found in the cytoplasm and the nucleus and demonstrate that it binds the KH domain protein encoded by the held out wings (how) locus (Baehrecke, 1997; Lo and Frasch, 1997; Zaffran et al., 1997) . Crn binds only to the cytoplasmic HOW protein HOW(S), suggesting that this protein acts to control the nuclear localization of the Crn splice factor. Furthermore, the single loss of either crn or how affects glial differentiation and both genes interact. Like its mammalian homolog Quaking, which is also required for glial differentiation, HOW(S) is implicated in the regulation of RNA splicing (Volohonsky et al., 2007; Nabel-Rosen et al., 2002; Park et al., 2004; Wu et al., 2002) . Using a GFPexon trap approach (Morin et al., 2001) , we identified nervana and neurexinIV, which both encode proteins located in septate junctions, as possible targets of crn and how function. In summary, our data suggest that the temporal control of mRNA splicing of specific target genes is pivotal for glial cell maturation and correct wrapping of axonal processes.
Results

Isolation of Mutants Affecting Glial Cell Migration
Within the embryonic nervous system of Drosophila, most glial cells of the peripheral nervous system (PNS) are born in the CNS (Sepp et al., 2000) . Within a relatively short time period, these glial cells migrate out along the motoaxons to occupy specific positions along the nerve to finally wrap the axons (Sepp and Auld, 2003b) . To decipher the genetic circuits controlling glial development, we conducted a phenotypic screen for X-chromosomal mutants affecting the differentiation of glial cells. In order to follow and determine the location of only a subset of peripheral glial cells, we used the enhancer trap J29-an insertion into the gliotactin gene (Auld et al., 1995; . In wild-type embryos, this marker labels four evenly spaced glial cells along the peripheral nerves ( Figure 1A ). The dorsal-most glial cell has its origin in the PNS and migrates toward the CNS ( Figure 1A ).
We identified a phenotypic group of mutants (26H8, 15H6, and 8H7) that share a block of glial cell migration into the periphery (in 92% of the hemisegments [n = 182], no migration occurred across the lateral muscle field, Figure 1 ). In addition, 98% of the peripheral glial cells born in the PNS fail to migrate toward the CNS (Figures 1A and 1B, arrow, n = 182) . The number of glial cells is not affected. This phenotypic group was subsequently found to be allelic to crooked neck.
crooked neck Affects Glial Cell Development
To determine the cellular phenotypes underlying the migration defects in crn mutants, we used the Mz97 Gal4 driver (Ito et al., 1995) , which expresses Gal4 only in the J29-positive peripheral glial cells (Edenfeld et al., 2006) . Expression of CD8::GFP in these cells shows that in wild-type embryos glial cells form a continuous sheath around the segmental and intersegmental nerves ( Figure 1E ). In crn mutants, most of the glial cell bodies are found close to the CNS/PNS transition zone where the Repo-positive nuclei are located ( Figure 1F ). Glial cell processes do not wrap the nerves; however, we detect thin glial processes close to the nerves ( Figure 1F ). In addition to the glial cell defects, the morphology of the oenocytes is affected, which in the wild-type form a ringlike structure around the chordotonal organs (Figure 1) .
To analyze the subcellular phenotype of crooked neck mutants, we undertook an electron microscopic analysis. In wild-type sections of stage 16 embryos, the segmental nerve axon bundles are always wrapped by an inner glial cell layer and an outer perineurial glial cell layer (Figures 2A and 2C ). Glial membranes are in close contact and toward larval stages form septate junctions that separate the inner layer against the surrounding hemolymph (Figures 2E and 2G) . Although distinct axonal fascicles can still be detected in stage 16 crooked neck mutant embryos, their association with glial membranes is impaired. Close to the CNS, where glial cell bodies reside in crn mutants, wrapping of axons is almost complete, but no clear morphological distinction can be made between the perineurial and the inner glial cell layer ( Figure 2B ). In areas with glial membrane-membrane contact, no signs of septate junction formation can be detected ( Figure 2F ). At dorsal positions of a wild-type nerve, glial cell membranes wrap tightly around the axons and perineurial glial cells cover the entire structure ( Figure 2C ). In crooked neck mutant embryos, however, only very thin glial processes can be detected that do not properly grow around the neuronal fascicles. Furthermore, many axonal profiles are not in contact with any glial cell process ( Figures 2D and 2H) .
These results suggest that crooked neck mutant glial cells are initially capable of sending out long cell processes, which extend toward their normal targets, but they fail to properly wrap the axons.
Identification of crooked neck Alleles
The lethality associated with the alleles 26H8 and 8H7 could be rescued by the duplication Dp(1;2;Y)w + . To identify the corresponding gene, we first determined the cuticle phenotype and found some resemblance to the crooked neck mutant phenotype (Zhang et al., 1991) . Further complementation analyses confirmed that we had induced crooked neck alleles (Zhang et al., 1991) . crn comprises two exons and encodes a protein of 702 amino acids that almost entirely consists of 16 tetratrico peptide repeats (TPRs) ( Figure 3A) . The 34 amino acid TPR motif is able to form an a-helical structure and mediates protein-protein interactions (Sikorski et al., 1990) . The Drosophila Crooked neck protein and its yeast and human homologs have been implicated in the regulation of splicing (Burnette et al., 1999; Chung et al., 1999 Chung et al., , 2002 Ohi and Gould, 2002; Park et al., 2004; Wang et al., 2003) .
To further verify that we had isolated crooked neck alleles, we sequenced the corresponding mutant DNAs. Figure 3A ).
Crooked Neck Is Found in the Cytoplasm and the Nucleus During embryonic development, crn is expressed ubiquitously (Zhang et al., 1991) . Recently, the Crn protein had been found in the nucleus in a speckle-like pattern (Raisin-Tani and Leopold, 2002) . We have confirmed these data but also found expression in the cytoplasm (see below). We generated additional antibodies to determine the distribution of Crn during development. These antibodies recognize a protein band of about 80 kDa in Western blots of protein extracts generated from wild-type embryos, which corresponds to the predicted size of 84 kDa ( Figure 3B ). In whole-mount preparations of embryos and imaginal discs, these antibodies detect a ubiquitous distribution of the Crn protein with a predominant localization in the nucleus. To demonstrate the specificity of the antisera, we generated transgenic animals carrying a UAS-crn RNAi construct. Following expression of double-stranded crn RNA in the posterior compartment of imaginal discs, Crn expression was drastically reduced ( Figure 3C ). In addition, we created fly strains that carry either an UAS-crn or an UAS-crn Myr construct. Expression of wild-type Crn in the engrailed domain resulted in an equal distribution of Crn in the cytoplasm and the nucleus, suggesting that the nuclear import is regulated ( Figures 3D and  3E 0 ). In addition, cytoplasmic Crn localization can be seen in the amnioserosa cells ( Figure 3E 0 ). The expression of the myristoylated Crn protein (Crn Myr ) leads to a membrane expression ( Figures 3F and 3G 0 ).
crn Acts Cell-Autonomously in Glial Cells Given the glial phenotype, we next analyzed the endogenous expression of Crn in glial cells. During all stages of development, the expression of Crn is observed in cells also expressing the glial marker Repo ( Figure 4A ). Toward the end of embryogenesis, expression in the glial nuclei becomes more distinct, suggesting that less Crn is present in the cytosol ( Figure 4A ). In order to determine whether crn is not only expressed but also required in glial cells, we performed rescue experiments of the crn mutant phenotype using the UAS/Gal4 technique. Ubiquitous expression of the wild-type Crn protein driven by the daughterless-Gal4 driver was able to rescue the mutant crn glial phenotype. Similarly, we were able to rescue the mutant phenotype using the locoGal4 driver line (Granderath et al., 2000) that is expressed in glial cells (see Figure S2 in the Supplemental Data available online). About 10% of the embryos showed no rescue, and in 10% only weak rescues were observed. As overexpression of Crn did not result in an abnormal mutant phenotype (data not shown), the partial rescue may be due to the expression system used. Furthermore, expression of the myristoylated Crn protein did not rescue the crn mutant phenotype, indicating that the normal localization of Crn is important for function. In summary, the data demonstrate that crn is required cell-autonomously to control glial cell maturation.
Crooked Neck Forms a Protein Complex with the RNA-Binding Protein HOW Crn and its yeast homolog Clf1p have been implicated in the splicing process, possibly by promoting the functional maturation of the spliceosome (Chung et al., 1999; Ohi and Gould, 2002; Raisin-Tani and Leopold, 2002; Wang et al., 2003) . Another RNA-binding protein implicated in RNA metabolism is encoded by the held out wings (how) gene (Volohonsky et al., 2007; Nabel-Rosen et al., 2002) . Its mammalian homolog Quaking participates in the RNA splicing of glial-specific target genes, and, furthermore, mutations in the mouse quaking gene affect the glial wrapping of axons (Ebersole et al., 1996; Sidman et al., 1964; Wu et al., 2002) . The Drosophila how locus encodes three different proteins, HOW(S), HOW(M), HOW(L), that differ in their C-terminal sequences but share an N-terminal KH-RNAbinding domain (Baehrecke, 1997; Lo and Frasch, 1997; Zaffran et al., 1997) . The newly discovered HOW (M) is not yet characterized. The HOW(L) protein carries a nuclear retention signal and is found only in the nucleus. HOW(S), on the other hand, is found in both the cytoplasm and the nucleus. To test a possible physical connection between Crn and HOW, we performed coprecipitation experiments using S2 cell extracts containing both Crn and HA-tagged HOW proteins (Figure In S2R + cells, coexpression of Crn and HOW(S) resulted in a prominent nuclear localization of HOW(S) and Crn ( Figure 4B ). When we coexpressed HOW(S) and the membrane-tethered form of Crn (Crn Myr ), the majority of the HOW(S) protein is excluded from the nucleus ( Figure 4C ). Thus, it appears that HOW proteins participate in the formation of a cytoplasmic protein complex containing Crn.
how Affects Glial Cell Development Given the fact that Crn and HOW proteins can form a complex, we wondered whether how mutant embryos also display a glial phenotype. Unfortunately, no isoform-specific mutants are available, and we thus analyzed the severe allele how e44
. Using the pan-glial marker Repo, we found glial positioning defects in zygotic how mutants similar to the ones seen in crn mutant embryos (Figures 1 and 5B-5D ). Peripheral glial cells do not migrate out from the CNS/PNS transition zone and accumulate at the nerve root ( Figure 5C ). Generally, the phenotypes were not as strong as in crn mutant embryos, and only about 60% of the hemisegments (n = 200) showed a severe phenotype. To visualize the cellular morphology of the peripheral glial cells, we expressed CD8-GFP in the Mz97 pattern. Similar to crooked neck mutant embryos, we found the glial cell bodies at the CNS/PNS transition zone and sometimes thin processes along the intersegmental and segmental nerves (Figure 5D) . In some segments, glial cells have migrated along the nerve but do not fully differentiate and fail to enwrap the axonal tracts ( Figure 5D ). In addition, the organization of the oenocytes is similarly affected in both crn and how mutant embryos; in some segments, the oenocytes are missing completely ( Figure 5D ). As anticipated by the phenotypic analyses, we found HOW expression in glial cells that show defects in the mutants ( Figures 5E-5G) .
We next conducted an ultrastructural analysis to investigate the glial cell morphology in stage 16 how e44 mutant embryos. Close to the CNS/PNS transition zone, the perineurial glia does not fully wrap around the subperineurial glia ( Figure 5H ). Further distal, glial cell processes are reduced in size, leaving some axons in direct contact with the hemolymph ( Figure 5I ). Thus, crn and how mutant phenotypes resemble each other on both the cellular and ultrastructural level. The crn phenotype, however, appears to be slightly more severe when compared to the how mutant phenotype.
Genetic Interaction between crooked neck and how Above, we have shown that both crn and how are required for glial cell development and demonstrated that the encoded proteins can be found in one complex. To test a possible genetic interaction, we generated crooked neck; how double-mutant embryos. By using marked balancer chromosomes, we could unambiguously identify double-mutant animals. The phenotype of crn; how double mutants corresponds to the crn loss-of-function phenotype, supporting the idea that both proteins act in a similar pathway ( Figure S3 ). In Expression of crn during development did not cause any abnormal phenotype, whereas expression of how(s) during wing development using the sd-Gal4 driver resulted in a small wing phenotype ( Figure 6C ). Coexpression of how(s) and crn did result in an additional 10% reduction in wing size as compared to the expression of how(s) alone ( Figure 6E ; n = 115 wings). Most notably, the formation of the anterior wing margin, including all sensory organs, is impaired; only 18% of the wings contain anterior wing margin structures. Upon expression of how(s) only, about 50% of the wings possess these structures ( Figure 6C ; n = 180). Expression of how(s) in a heterozygous crn mutant background leads to a partial rescue of the wing size ( Figure 6D , n = 124). Coexpression of HOW(S) and Crn Myr leads to an even more pronounced suppression of the dominant wing phenotype ( Figure 6F ; n = 160). This suggests 
that-as seen for S2R
+ cells-the membrane-tagged Crn protein competes with the endogenous Crn protein for HOW(S) binding and renders HOW(S) in a nonfunctional state at the membrane.
These studies indicate that HOW(S) and Crn function together. Whereas overexpression of Crn has no effect on wing development, increased levels of Crn can be functional in the presence of HOW(S). Similarly, a reduction of crn function suppresses the HOW(S) gain-offunction phenotype.
Identification of crn Target Genes
In recent studies, both Crn as well as HOW were found to regulate splicing (Volohonsky et al., 2007; Park et al., 2004) . To understand how Crn controls glial differentiation, we went on to identify possible target genes that are spliced under the influence of Crn. Since Crn does not directly bind to RNA, no computational approach can be followed to trace candidate genes. HOW(S), which binds to Crn, does bind RNA, but the binding site comprises only five conserved nucleotides (Israeli and The shape of the J29-expressing glial cells is visualized using the Mz97 Gal4 driver and a UASmCD8:GFP (red); glial nuclei are labeled by Repo staining (blue). The Mz97-expressing glial cells fail to properly extend. In some cases, glial cells have apparently migrated but lose contact to the following cells (arrow; compare to Figure 1E ). In some segments, thin processes can be detected along the peripheral nerve (arrowhead). 
The oenocytes fail to form or do not properly differentiate (asterisks). (E-G) J29-positive glial cells express b-galactosidase ([E], red) and HOW ([F], green). (G) Merge. (H and I) Electron microscopic images taken from stage 16 how e44 mutant embryos. (H) Close to the CNS/PNS transition zone, phenotypes are not pronounced; however, perineurial glial cells (dotted yellow line) do not properly extend processes around the inner glial cell (red dotted line). (I) In more dorsal regions, glial cell processes only poorly wrap around the segmental nerves (arrowheads). Some axons appear to be not wrapped by glial membranes (dotted box is shown in higher magnification).
(E) Coexpression of how(s)
and crn leads to a reduced size of the wing blade. Most notably, the formation of the anterior wing margin is impaired (asterisk).
82% of the wings show a phenotype as indicated (n = 200). (F) Coexpression of how(s) and crn
Myr using the sd-Gal4 driver leads to a 15% increase of the wing size (n = 70). sd-Gal4 driven expression of crn or crn Myr alone does not result in a mutant phenotype. NeuronT.V., unpublished data). To nevertheless identify target genes, we utilized the GFP-exon trap technology that generates genes tagged with a GFP-exon cassette (Morin et al., 2001 ). We mobilized a P[GFP]-exon cassette and isolated about 400 insertion events that led to GFP expression during embryogenesis (U.L. et al., unpublished data). We next tested whether GFP expression of lines, i.e., neurexinIV-GFP; lachesin-GFP; nervana-GFP; Na/P symporter-GFP, is dependent on crn function. Upon false or failed splicing of these endogenously tagged genes, the corresponding mRNA is either not transported to the cytoplasm or translation is prematurely terminated.
In a crn mutant background, expression of the Nervana2-GFP fusion protein was specifically reduced in the nervous system, suggesting that Crn may modulate splicing efficiency in a tissue-specific manner ( Figures  7A and 7B) . Expression of the NeurexinIV-GFP fusion protein was reduced below detection level in the nervous system, whereas it appeared unchange in the ectoderm ( Figures 7C and 7D ).
The RNAs generated by the neurexinIV gene contain multiple putative HOW binding sites ( Figure 7E ). Four sites are clustered in the central region of the neurexinIV gene where alternative splicing is predicted to occur (BDGP, Figure 7E) . A minigene that includes this region together with three introns was fused to GFP and transfected into S2R + cells ( Figure 7F ). As a result, prominent GFP expression driven by this construct was noted in wild-type S2R + cells ( Figure 7G ). When we suppressed crn function by RNA interference, GFP expression was significantly reduced ( Figure 7H ). Finally, we asked whether the nrx-GFP mRNA can bind to HOW(S). Indeed, HOW(S) can bind in vitro-transcribed nrx-GFP RNA but not the antisense strand RNA. When we added a mutated form of HOW(S) that cannot bind RNA [HOW (S) e44 ], no binding was observed, demonstrating that HOW(S) can specifically bind to nrx-GFP RNA ( Figure 7I ).
To address the question whether crn affects RNA splicing in glial cells, we generated flies carrying a UAS::nrx-GFP minigene construct. Following the activation of nrx-GFP expression using the repo::Gal4 driver, most glial cells expressed GFP in wild-type embryos, whereas in crn mutants, GFP expression appears absent from some glial cells ( Figure 8B ). Since in both genotypes the transcriptional control of the nrx-GFP minigene is identical, different GFP expression levels may result from either an effect on RNA processing or translation. To discriminate between these possibilities, we isolated polyA + RNA and determined the splicing pattern using primers specific for the nrx-GFP transgene ( Figures 8C  and 8D ). Sequence analysis of the different splicing products showed that in wild-type embryos primarily exons 1, 3, 4 and 1, 4 are joined. In the absence of Crn, however, exon 1, 4 splicing is favored, demonstrating that Crn is able to modulate the splicing pattern of the nrx-GFP minigene ( Figure 8C ). + cells were treated with crn dsRNA, 24 hr later, cells were cotransfected with UAS::nrx-GFP and act::Gal4. After 2 additional days, expression of Crn and GFP was monitored by Western analysis as indicated. The Nrx-GFP protein, which is slightly larger compared to GFP due to the Nrx fusion (arrow head), does not appear to be stable and degrades (lower band). To control loading of the gel, we used anti-b-tubulin antibodies. (I) In vitro-translated HOW(S) protein binds to RNA generated from the nrx minigene. No binding was observed to the antisense strand. Similarly, the HOW(S) e44 mutant was not able to bind RNA generated from the nrx minigene.
In conclusion, here we have shown that glial cell maturation depends not only on the regulation of gene transcription but is also controlled at the level of mRNA splicing. We show that the Crn splice factor forms a complex with the RNA-binding protein HOW to modulate the splicing of genes known to be required for late glial differentiation.
Discussion
Wrapping of single or groups of axons is a fundamental process in the developing nervous system. Most glial cells of the Drosophila PNS are born in the CNS and migrate toward their final destination. Subsequently, the cell body follows to then initiate wrapping of the axons (Figure 9 ). Here we present the identification of two genes, crn and how, that are both required for the initiation of axonal wrapping. The proteins encoded by crn and how are involved in the regulation of splicing of components of the septate junctions that were previously shown to be required for glial cell differentiation. Crn and HOW(S) interact in the cytosol to control their nuclear import, providing a simple mechanism to couple glial and neuronal cell differentiation.
crn encodes an unusual TPR-containing protein whose function is essential for embryonic development (Zhang et al., 1991) . The Crn protein is found in the cytosol and in nuclear ''speckles'' (Raisin-Tani and Leopold, 2002) . Previous genetic and biochemical evidence has already suggested that Crn and its homologs participate in the assembly and the control of the splicing machinery (Burnette et al., 1999; Chung et al., 1999 Chung et al., , 2002 Park et al., 2004; Raisin-Tani and Leopold, 2002; Wang et al., 2003) . A mutation of the yeast crooked neck ortholog results in the accumulation of unspliced pre-mRNAs and, furthermore, Crn-like proteins are needed for pre-mRNA splicing in vitro (Ben-Yehuda et al., 2000a , 2000b Chung et al., 1999; Russell et al., 2000) . Crn is found in two functional complexes with and without snRNA and via its N-terminal TRPs helps to assemble the intact spliceosome (Wang et al., 2003) . Within the spliceosome, the Crn homolog assists in the initial spliceosome assembly and also binds the phospho-CTD of the RNA polymerase II (Gasch et al., 2005) . In crn mutants, we have observed changes in the splicing pattern suggesting that Crn modulates splicing preferences during alternative splicing.
Alternative splicing employs differential use of 5 0 or 3 0 splice sites and has evolved as an efficient way to achieve a functional diversification and regulation of gene products (Matlin et al., 2005) . The basic splicing mechanism first requires the correct choice of 5 0 and 3 0 splice junctions and subsequently the assembly of the spliceosome. While Crn can facilitate spliceosome assembly, it does not directly participate in the selection of specific splice junctions, as the Crn protein is not able to bind to RNA. However, in Drosophila, Crn does regulate alternative splicing of few specific target genes, implying the existence of interaction partners that direct the Crn protein to these target RNAs (Burnette et al., 1999; Park et al., 2004 ).
Here we have identified the HOW(S) protein as such an interaction partner that is likely able to recruit Crn to specific splicing targets. The HOW proteins contain an hnRNP K homology (KH) motif and exhibit specific RNA-binding activities. The KH motif is found in the GSG domain (GRP33, Sam68, GLD) shared by the Signal Transduction and Activation of RNA (STAR) family of proteins (Vernet and Artzt, 1997) . The how locus is genetically complex: it encodes two antagonizing splice variants, HOW(S) and HOW(L), the functions of which were thoroughly analyzed in tendon cells (Nabel-Rosen et al., 1999 , 2005 . Here, HOW(L) is involved in the instability of stripe mRNAs, whereas HOW(S) is involved in mRNA stability as well as in the control of stripe A splicing (Volohonsky et al., 2007) . Since HOW(S) associates with Crn, a direct influence on splicing can be anticipated.
The proposed cytoplasmic-nuclear shuttling of a Crn/ HOW(S) complex furthermore allows the linking of extracellular signals to a direct control of splicing (Figure 9 ). Concerning glial cell differentiation, this suggests that wrapping of axonal fascicles is not only dependent on a transcriptional control. It is rather likely that neuronal signals help to efficiently couple glial and neuronal differentiation by directly influencing the splicing pattern.
The nature of such a signal is still elusive, however. As described for the HOW-related protein Sam68, phosphorylation may be important to control the interaction of Crn and HOW in the cytoplasm and thus the transport of the complex into the nucleus (Matter et al., 2002) . In this respect, it is interesting to note that the development of oenocytes, which is impaired in both crn and how mutants, requires EGF-receptor signaling (Brodu et al., 2004) and that neuronal EGF-receptor signaling was shown to regulate glial expression of neuroglian (Sepp and Auld, 2003a) .
In agreement with such a model is our finding that the how mutant phenotype resembles the phenotype caused by the loss of crn. Furthermore, Crn is only able to bind cytosolic HOW(S). If HOW(L) expression is forced to the cytosol, it can also bind to Crn, confirming that the interaction of Crn and HOW occurs in the cytosol. The assembly of the Crn/HOW complex is crucial to precisely regulate the nuclear concentration of these splice factors, which in turn is relevant for alternative splicing (Park et al., 2004) . Within the nucleus, HOW(S) binds to a consensus sequence with a length of only five nucleotides, making the quest for specific target genes difficult. To nevertheless get insight into this important functional aspect, we utilized a collection of strains in which endogenous genes were tagged by the insertion of a GFPexon. Here we identified two components of the septate junctions that form important autocellular junctions needed to stabilize glial cell morphology (Banerjee et al., 2006) as candidate targets for Crn. Glial septate junctions are morphologically established by the end of embryogenesis (Tepass and Hartenstein, 1994) . In line with the notion that neurexinIV is a target gene of crn, we failed to detect septate junctions in crn mutant glial cells. Furthermore, dye-penetration experiments show that the blood-brain barrier, which crucially depends on the presence of septate junctions , is not established in crn mutants (A. Krudewig and C.K., unpublished data).
In addition to regulating splicing, Crn and HOW proteins may also have additional functions. For example, members of the hnRNP-A/B family of RNA-binding proteins are able to regulate alternative splicing of the Drosophila P element transposase and the Ubx gene (Burnette et al., 1999; Pozzoli and Sironi, 2005) . However, the function of the hnRNP-A/B family member Hrp48 is not restricted to the control of RNA splicing since it is also involved in the control of oskar mRNA localization in the Drosophila oocyte (Huynh et al., 2004; Yano et al., 2004) . Such a dual specificity of the Hrp48 RNAbinding protein in regulating RNA splicing and RNA transport has also been suggested for the Crn-binding partner HOW. In addition, it was recently demonstrated that the yeast Crn homolog also affects DNA replication (Zhu et al., 2002) , and first phenotypic analyses of the Drosophila crn mutant led to the proposal that Crn might play a role in regulation of cell divisions (Zhang et al., 1991) . However, we have not observed any abnormal cell number for the peripheral glial cells, suggesting that at least during glial development crn has no function during the cell cycle.
Our data lead to a model underlying glial cell differentiation that may not only be applicable for Drosophila (Figure 9 ). The vertebrate homolog of how is the quaking gene, which is also required for glial differentiation. quaking viable mutants initially develop normally but then show tremors due to severe myelination defects (Sidman et al., 1964) . The mutant phenotype is caused by a deletion in the promoter region of the quaking gene that encodes several alternatively spliced mRNAs (QKI-5; QKI-6; QKI-7) (Ebersole et al., 1996) . The quaking viable deletion abrogates the expression of QKI-6 and QKI-7 in myelinating cells of the brain (Hardy, 1998) . The complete loss of quaking transcripts results in early lethality (Chen and Richard, 1998; Cox et al., 1999) . quaking and how mutants not only share a defect in axonal wrapping. Moreover, the corresponding gene products appear to have different functions in the nucleus and the cytosol. Whereas QKI-5 is strictly nuclear, QKI-6 and QKI-7 are able to shuttle between the cytosol and the nucleus as it has been observed for the HOW(S) protein. The position of putative QKI binding sites close to tissue-regulated exons was found to be conserved in mice (Sugnet et al., 2006) and is similar to what we found for the putative HOW binding sites in neurexinIV. Thus, although invertebrates and vertebrates have long been thought to follow very different routes toward glial differentiation, the underlying molecular control of glial wrapping may be conserved.
Experimental Procedures Genetics
All crosses were performed on standard food at 25 C. The following fly stocks were used: w 1118 as wild-type control, how e44 (Zaffran et al., 1997) , UAS-how(s) (Nabel-Rosen et al., 1999) , J29 (Klä mbt and Goodman, 1991), Mz97 (Ito et al., 1995) , loco::Gal4 (Granderath et al., 2000) , repo::Gal4 (Lee and Jones, 2005) , UAS::mCD8-GFP (Lee and Luo, 1999) , sd::Gal4, en::Gal4, Dp(1;2;Y)w + (all Bloomington). The crn alleles 8H7; 15H6; 26H8 were identified in a screen for EMS-induced glial cell migration mutants. To generate GFP-exon insertion lines, we followed the procedure outlined by Morin et al., 2001 . A full-length crn cDNA (Zhang et al., 1991) was subcloned in pUAST (Brand and Perrimon, 1993) or pUAST-Myr (Bogdan et al., 2005) and used for germline transformation to generate UAS::crn and UAS::crn Myr . To generate the UAS::crn RNAi construct, a 500 bp fragment was amplified (5 0 TGCAGCGAGCACGCAAAGCTCTAGAC TTGG 3 0 and 5 0 CTGCACGTTCAGCTCCGCATCTAGACCGCT 3 0 ) and cloned into pWIZ (Lee and Carthew, 2003) . To generate the nrx-GFP minigene, we used the primers 5 0 TAACgGATCcAGAGTTTG CCG 3 0 and 5 0 TAATGtcTAGAGTTGCCATCGGAG 3 0 , which added BamHI and Xba, respectively. The corresponding fragment was cloned in a pUAST-eGFP vector.
Immunhistochemistry Whole-mount embryos were fixed and stained as described (Hummel et al., 1999) . S2R + cells transformed act::Gal4, UAS::how(s), and UAS::crn were processed as described (Bogdan et al., 2005) . Guinea pig anti Crn antibodies were used at 1:1000, anti-HOW antibodies (rat) were used at 1:250. Confocal images were taken on a Zeiss LSM 510 Meta. Wings were mounted in Hoyers medium and photographed using a Zeiss Axiophot.
Electronmicroscopic Analysis
Homozygous mutant embryos were selected using GFP-carrying balancer chromosomes (Bloomington Stock Center). Embryos were prefixed for 20 min in 18% glutardialdehyde at room temperature. Embryos were processed as described (Stollewerk and Klä mbt, 1997; Stollewerk et al., 1996) . The vitelline membrane was removed by hand, and the embryos were then fixed on ice in 1% OsO 4 and 2% glutardialdehyde in PBS for 30 min and then in 2% OsO 4 in PBS on ice for 30 min. Following en block contrasting and embedding in Epon, 60-80 nm thick sections were taken and viewed using a Zeiss EM900.
Generation of Antibodies
The crn ORF was cloned into pGEX-4T1 using the primers: 5 0 ACAGA AGGAATTCAAGGTGGCCAAG 3 0 and 5 0 CTTTGCTCGAGAGAGCGA TTTTTAGGCGGAA 3 0 . Expression of the Crn-GST fusion protein was induced in BL21 cells in 23 YTA-medium with 0.1 mM IPTG at 18 C overnight. Following purification, 1 mg protein was used to immunize guinea pigs (Eurogentec). All secondary antibodies were from Invitrogen (Karlsruhe).
Transient Transfection of S2 Cells
S2 and S2R
+ cells were grown in Schneider's medium supplemented with 10% fetal-calf serum and 1% pen-strep solution (Biological Industries). For transfection, cells were seeded at 3.5-5 million cells in 4.5 ml medium per 50 ml flask (Falcon) and allowed to adhere for several hours. Transfection of DNA into cells was performed using FuGene (Roche). 12 mg DNA was used for each transfection. 14-18 hr after transfection, medium changed. 36-40 hr after transfection, cells were collected for analysis. Typically, cells were transfected with the various UAS constructs together with a Bluescript vector containing Gal4 under the actin promoter. In each experiment, the amount of pUAST vector in the different transfections was equalized using an empty pUAST vector.
Western Analysis of Cell Extracts
Cells were collected by centrifugation, washed twice in PBS, and resuspended in RIPA buffer (50 mM Tris HCl [pH 7.5], 150 mM NaCl, 0.1% SDS, 1% NP40, 1% deoxychrotic acid, 1% protease inhibitor cocktail P8340, Sigma) and kept on ice for 10 min. Embryos were crushed in RIPA buffer and kept on ice for 10 min. RIPA-soluble fraction (total cell/embryo extract) was isolated by centrifugation, 13,000 3 g, 10 min at 4 C. Extracts were boiled in protein sample buffer (20 mM Tris-HCl [pH 8.5], 10% glycerol, 3% SDS). Protein concentration of extracts was determined using the Bradford reagent (Bio-Rad). 10-20 mg protein were loaded in each lane. Protein extracts were run on 8%-10% PAA gels and transferred to nitrocellulose membranes. Membranes were blocked in 10% low-fat milk diluted in PBS + 0.1% Tween-20, reacted with primary and secondary-HRP-conjugated antibodies (Jackson). Super Signal chemiluminescent substrate (Pierce) was used for signal detection.
Immunoprecipitation from Cell Extracts
Cell extracts were prepared as for Western analysis. Cells were extracted in NP40 lysis buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% NP40, supplemented with protease inhibitors). Protein A/G sepharose beads were reacted with anti HA antibody (Babco) and added to lysates. The mixture was rocked at 4 C for 1-2 hr. Beads were washed in lysis buffer and then boiled in protein sample buffer for Western analysis of proteins bound to the beads.
In Vitro RNA-Binding Assay The protein-RNA-binding assay was performed as described (Nabel-Rosen et al., 1999) . The nrx minigene sequence (lacking the GFP part) was used as a template to produce biotin-labeled RNAs (Biotin labeling mix, Roche, and T7 polymerase, Promega). The biotin-labeled RNA was purified on G-50 Sephadex Quick Spin Column (Roche) and then mixed with in vitro-translated HOW(S) or HOW(S) e44 HA-tagged proteins (TNT Coupled Reticulocyte Lysate System, Promega) and precipitated with magnetic Streptavidin beads (Promega). Binding was performed by adding w1 mg of biotin-labeled RNA to 5 ml of the translated How proteins. Streptavidin-magnetic beads were first washed with binding buffer, and 300 ml of the beads was added to each reaction for 25 min at room temperature. The magnetic beads were then isolated, washed, and boiled in sample buffer. The supernatant was analyzed by Western analysis with anti-HA antibodies. As a nonspecific RNA control, RNA was transcribed from the nrx complementary strand.
RNA Isolation and Splicing Analysis
Twenty stage 16 embryos were homogenized in 30 ml Trizol (Invitrogen), subsequently 170 ml Trizol was added, and RNA extraction was performed according the manufacturer's instructions (Invitrogen). Following isopropanol precipitation, the RNA was resuspended in 40 ml (S2 cells) or 15 ml (embryos) DEPC H 2 O. To 1 mg total RNA, 1 ml oligo dT [0.5 mg/ml], 1 ml dNTP (10 mM) were added in a total volume of 12 ml DEPC H 2 O. Following incubation at 65 C for 5 min, the reaction was put on ice, 4 ml 53 buffer, 2 ml 0.1 M DTT, 1 ml RNAase inhibitor were added and the reaction was incubated for 2 min at 42
C. Following addition of 1 ml superscript reverse transcriptase, the reaction incubated 50 min at 42 C and 15 min at 70 C (Invitrogen). Subsequent PCR was performed using the following primers 5 0 AAC TTG TGG CCG TTT ACG T 3 0 and 5 0 TAA CGG ATC CAG AGT TTG CCG 3 0 for 30 cycles (52 C 45 min, 72 C 75 min).
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.neuron.org/cgi/content/full/52/6/969/DC1/.
